Skip to content
healthcare.dev

ACD-A

NDC 0942-0641, Anticoagulant Citrate Dextrose Solution Formula A, solution, from Fenwal, Inc..

Product NDC
0942-0641
Status
Listed
Labeler
Fenwal, Inc.
Dosage form
SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
BN160918
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0942-0641 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEXTROSE MONOHYDRATE24.5 g/1000mL
  • SODIUM CITRATE, UNSPECIFIED FORM22 g/1000mL
  • ANHYDROUS CITRIC ACID7.3 g/1000mL

Pharmacologic classes

Acidifying Activity [MoA]; Acidifying Activity [MoA]; Anti-coagulant [EPC]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Calculi Dissolution Agent [EPC]; Decreased Coagulation Factor Activity [PE]; Decreased Coagulation Factor Activity [PE]

Package NDCNDC-11Package
0942-0641-0300942064103500 mL in 1 BAG (0942-0641-03)
0942-0641-04009420641041000 mL in 1 BAG (0942-0641-04)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels?ndc=0942-0641

Use it

Look up 0942-0641 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0942-0641 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0942-0641. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.